Related Experiment Video
Updated: Apr 23, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
[TNF inhibitors and myelitis: think about it, even lately]
Marie Stève-Dumont1, Mikael Cohen2, Christine Lebrun-Frenay2
1Centre régional de pharmacovigilance Nice Alpes-Côte d'Azur, CHU, Nice, France.
Abstract:
Anti-TNF medications have been widely used for the treatment of auto-immune disease and new drugs are regularly approved. We report here a case of late myelitis after more than 6 years of adalimumab in a 74-year-old woman treated for rheumatoid polyarthritis.
More Related Videos
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Diphtheria
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Myocarditis III: Medical Management